Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Tra

NBIX earnings call for the period ending September 30, 2021.

Related Keywords

United States , America , Morgan Stanley , Todd Tushla , Josh Schimmer Evercore , Chris Shibutani , Eiryw Roberts , Paul Matteis Stifel , Kyle Gano , Myles Minter William Blair , Phil Nadeau Cowen , Carter Gould Barclays , Josh Schimmer , Laura Chico , Piper Sandler , Eddie Hickman Guggenheim , Matthewc Abernethy , Phil Nadeau , Brian Skorney Baird , Eric Benevich , William Blair , Neena Bitritto Garg , Anupam Rama , Charles Duncan , Kevinc Gorman , Charles Duncan Cantor Fitzgerald , Carter Gould , Laura Chico Wedbush , Paul Matteis , Matt Abernethy , Brian Abrahams , Brian Skorney , Myles Minter , Yatin Suneja , Eiry Roberts , Kelly Shi Jefferies , Chris Shibutani Goldman Sachs , David Amsellem , David Amsellem Piper Sandler , Tazeen Ahmad , Kelly Shi , Kevin Gorman , Neurocrine Biosciences Inc , Psych Congress , Goldman Sachs , Cantor Fitzgerald , Company Analyst , Barclays , Tazeen Ahmad Bank , Business Development , Neurocrine Biosciences , Neurocrine Biosciences Reports Third Quarter , Vice President , Investor Relations , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Chief Commercial Officer , Chief Business Development , Tardive Dyskinesia Impact Scale , Clinical Global Impression Severity Score , Social Performance , Jeff Hung , Ami Fadia , Vamil Divan , Mizuho Securities ,